Mesa Laboratories Inc. (MLAB)
Summary
Mesa Laboratories, Inc. (MLAB) Q1 2027 Earnings Call Transcript
Mesa Laboratories, Inc. (MLAB) Q1 2027 Earnings Call Transcript
Mesa Laboratories Q1 Earnings Call Highlights
Mesa Laboratories NASDAQ: MLAB reported first-quarter fiscal 2027 revenue growth of 1%, improved operating margins and continued debt reduction, while newly appointed President and CEO Siddhartha Kadia outlined plans to address fulfillment issues in its Sterilization and Disinfection Control business and accelerate product development in Biopharmaceutical Development.
Mesa Laboratories, Inc. (MLAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Mesa Laboratories, Inc. (MLAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Mesa Laboratories Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 109 | $9,468.85 | $10,988.29 | $1,519.44 | 16.05% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 83 | $22,085.82 | $9,232.09 | -$12,853.73 | -58.2% |
 Point72 Asset Management LP Point72 Asset Management LP | 22,514 | $1.93M | $2.39M | $461,138.29 | 23.94% |
 Matthew Carney Nfj Investment Group LLC | 14,256 | $1.42M | $1.45M | $29,795.04 | 2.1% |
 Joseph Castro Nuveen LLC | 13,896 | $1.58M | $1.41M | -$163,127.89 | -10.36% |
Mesa Laboratories Inc. (MLAB) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Mesa Laboratories Inc. ever had a stock split?
Mesa Laboratories Inc. Profile
| Automobile Components Industry | Consumer Discretionary Sector | Siddhartha C. Kadia CEO | NASDAQ (NGS) Exchange | 59064R109 CUSIP |
| US Country | 717 Employees | 31 Aug 2026 Last Dividend | - Last Split | 25 Jan 1995 IPO Date |
Overview
Mesa Laboratories, Inc. is a prominent player in the life sciences industry, focusing on the development, manufacturing, and sale of tools and quality control products and services. The company's operations span across North America, Europe, the Asia Pacific, and other international markets, catering to the diverse needs of the clinical genomics, sterilization and disinfection control, biopharmaceutical development, and calibration solutions sectors. Founded in 1982, Mesa Laboratories, Inc. has established itself as a pivotal entity, providing innovative solutions in various therapeutic areas including hereditary disease screenings, pharmacogenetics, oncology applications, and more. The company's unique positioning and extensive product range allow it to serve a wide array of industries including hospitals, dental, medical device, and pharmaceutical industries.
Products and Services
- Clinical Genomics - This segment focuses on the development, manufacture, and sale of genetic analysis tools. The MassARRAY system, along with consumables such as chips, panels, and chemical reagent solutions, enables clinical laboratories to perform genomic testing across various therapeutic areas, including hereditary diseases, pharmacogenetics, and oncology-related applications.
- Sterilization and Disinfection Control - Mesa Laboratories produces biological, cleaning, and chemical indicators to assess the effectiveness of sterilization and disinfection processes. These products find their application in hospitals, dental offices, medical device, and pharmaceutical industries. Additionally, this segment offers testing and laboratory services primarily aimed at the dental industry.
- Biopharmaceutical Development - This area includes the development, manufacture, and sale of automated systems for protein analysis and peptide synthesis solutions. The segment provides equipment and solutions for protein analysis, including analysis equipment, CDs, kits, and buffers. It also supplies peptide synthesizers used for automating chemical synthesis of peptides for peptide therapies, biomaterials, cosmetics, and general research.
- Calibration Solutions - Catering to health and safety regulations, this segment designs, manufactures, and markets products for measuring or calibrating temperature, pressure, pH, and humidity. Products are utilized in hospitals, medical device manufacturing, pharmaceutical manufacturing, and laboratory environments. The comprehensive product line includes continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems.
